Sign Up | Log In | What is SocialPicks?

The Rock-Star Investors Next Door

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Mike Havrilla twitter.com/mikehavrilla

Start Tracking Mike Havrilla - Add to Friends - Send Message

Community Rank: Principal (7000 pts) | Member since 07/15/2008

Picks Performance:

Outperforms

73%

of community

What's this?

All-time Return +1.04% (in 1 year)	Risk (SD) Conservative 0.00%	Sharpe Ratio -2.09
Followers 68	Winning Picks 786 of 1807	Total Views 945599

Overview

Stocks

Stats

Community

Widget

Shared Picks | Personal Portfolio | Voted Picks | Commented On

View: Shared Picks (Quick) / (Detailed) | Personal Portfolio

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
DNDN		11/28/09	+0.07%	+0.00%	+0.07%	Cancer Vaccines: Investing Opportunities ..	9
UNIFF	N/A	11/28/09	n/a	+0.00%	n/a	Unilife (UNIFF.PK) CEO Video Interview on..	1
CLDA	N/A	11/26/09	+7.71%	+0.00%	+7.71%	BioMed Research Reports: Clinical Data (N..	9
PBIO	N/A	11/24/09	-9.25%	+0.00%	-9.25%	Under the Radar Healthcare Stocks: Protox..	9
PUMD	N/A	11/23/09	n/a	+0.00%	n/a	BioMed News Bytes: Transcept, SciClone, P..	1
SCLN	N/A	11/23/09	-8.49%	+0.00%	-8.49%	BioMed News Bytes: Transcept, SciClone, P..	9
TSPT	N/A	11/23/09	-39.16%	+0.00%	-39.16%	BioMed News Bytes: Transcept, SciClone, P..	9
ABIO		11/23/09	+33.80%	+0.00%	+33.80%	BioMed News Bytes: Transcept, ProUroCare,..	9
NVO		11/22/09	+1.45%	+0.00%	+1.45%	Diabetes Care: Global Investing Opportuni..	9
BIO		11/19/09	-0.70%	+0.00%	-0.70%	Echo Therapeutics: Positive Developments ..	9
ECTE	N/A	11/19/09	n/a	+0.00%	n/a	Echo Therapeutics: Positive Developments ..	1
ABT		11/19/09	+1.13%	+0.00%	+1.13%	Epinex Diagnostics: A New Paradigm for Di..	9
JNJ		11/19/09	+3.27%	+0.00%	+3.27%	Epinex Diagnostics: A New Paradigm for Di..	9
CERS		11/17/09	+25.78%	+0.00%	+25.78%	BioMed News Bytes: GeoVax, Cerus, Discove..	9
GENZ		11/16/09	-0.02%	+0.00%	-0.02%	BioMed News Bytes: Genzyme, OSI Pharma, P..	9
CYTX		11/16/09	+65.05%	+0.00%	+65.05%	BioMed News Bytes: Cytori, Poniard, Alker..	9
NFES	N/A	11/14/09	n/a	+0.00%	n/a	NF Energy (OTC: NFEC.OB): 3Q09 Revs $7.57..	1
CVA		11/13/09	+1.55%	+0.00%	+1.55%	Waste2Energy (OTC: WTEZE.OB): A Local, Gr..	10
ACCP		11/11/09	n/a	+0.00%	n/a	Access Pharma (OTC: ACCP.OB): MuGard Laun..	1
IMUC	N/A	11/09/09	n/a	+0.00%	n/a	ImmunoCellular (OTC: IMUC.OB): Griffin Ma..	1

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
next »

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
DNDN		11/20/09	-2.51%	+0.00%	-2.51%	BioMed News Bytes: CombinatoRx, Dendreon,..	9
UNIFF	N/A	11/19/09	n/a	+0.00%	n/a	BioMed News Bytes: AstraZeneca, Delcath, ..	1
PBIO	N/A	09/19/09	-9.46%	+0.00%	-9.46%	Pressure BioSciences (NASDAQ: PBIO): A Ne..	10
TSPT	N/A	08/03/09	-46.56%	+0.00%	-46.56%	FDA Calendar Updates: Former Extreme Trad..	9
ABIO		06/01/09	-15.79%	+0.00%	-15.79%	13 Extreme FDA Trades: BioMedReports.com ..	9
NVO		04/01/09	+31.98%	+0.00%	+31.98%	FDA, Clinical Trial Calendar Updates: Wei..	9
DNDN		11/04/09	+5.55%	+0.00%	+5.55%	New Global Equity Index to Track Immunoth..	9
UNIFF	N/A	10/29/09	n/a	+0.00%	n/a	Unilife (OTC: UNIFF.PK): Medical Device I..	1
ABT		06/04/09	+18.76%	+0.00%	+18.76%	FDA Calendar Updates: ABT, AFFY, AZN, LLY..	9
JNJ		07/15/09	+5.70%	+0.00%	+5.70%	BioMedReports: FDA Calendar Updates	9
GENZ		08/07/09	+3.73%	+0.00%	+3.73%	Genzyme: Robust Growth Prospects at Clear..	9
PARD		05/14/09	-48.75%	+0.00%	-48.75%	10 Extreme Trades on Pending Clinical Tri..	9
CYTX		10/16/09	-0.53%	+0.00%	-0.53%	BioMed News Bytes: Cytori (NASDAQ: CYTX),..	9
NFES	N/A	11/07/09	n/a	+0.00%	n/a	ProActive HavRx Stock Indexes: Highlights..	1
ACCP		10/25/09	n/a	+0.00%	n/a	FDA Calendar November Stocks: Turkeys or ..	1
IMUC	N/A	11/07/09	n/a	+0.00%	n/a	ProActive HavRx Stock Indexes: Highlights..	1
EXAS		11/03/09	+6.48%	+0.00%	+6.48%	EXACT Sciences (NASDAQ: EXAS): Patience R..	9
NFES	N/A	10/17/09	n/a	+0.00%	n/a	NF Energy (OTC: NFEC.OB): An Efficient Ch..	1
IMUC	N/A	10/27/09	n/a	+0.00%	n/a	ImmunoCellular (OTC: IMUC.OB): Impressive..	1
ESALY	N/A	07/02/09	n/a	+0.00%	n/a	FDA Calendar Updates: ACUR, KG, MYRX, NEP..	1

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
next »

Similarity to Me ?

Compare Your Portfolio With Mike Havrilla: Enter stocks you like & track your portfolio:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Mike Havrilla

Investment Style:
Moderate [?]

Avg exp holding time:
87.99 days

Age: 30's	Occupation: Online Media Entrepreneur
Location: USA

Website:
twitter.com/mikehavrilla

About Me:

Mike Havrilla is an index developer, pharmacist, writer, and Co-Founder of BioMedReports.com with ex ... more

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.